CD7 and neoplasm: They constructed monovalent CD7-CAR-NK-92MI and bivalent dCD7-CAR-NK-92MI cells using the CD7 nanobody VHH6 sequence and found that they exhibited high efficiency and specific anti-tumor activity on T-cell leukemia cell lines and primary tumor cells.